Biotechnology Headlines from PR Newswire

< Go Back

First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development
Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research
LabStyle Innovations Announces the Initial Launch of the Dario™ Diabetes Management Solution for Android Devices
Global Genomics Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Life Technologies, Qiagen and Illumina
How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video
WaferGen Bio-systems Announces a Commercial Partnership with a Major Molecular Diagnostic Laboratory
The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology"
BioNano Genomics Announces the Purchase of the Irys System by BGI
Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market
Orexigen Therapeutics to Host Second Quarter 2014 Financial Results Conference Call and Webcast
Cipla and BioQuiddity Announce EU Commercial Partnership for OneDose-ReadyfusOR for Post-Surgical Pain Management
Expanded Data on Disability and Cognitive Improvements in Phase II Study of Synthetic Biologics' Trimesta™ in Multiple Sclerosis to be Presented at 2014 Joint ACTRIMS-ECTRIMS Meeting
Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan
Marken Expands Miami Regional Logistics Center
BioLife Solutions to Report Financial Results for Second Quarter 2014 and Provide Business Update on August 7, 2014
Institute for Supply Management, Michigan State University to recognize companies with excellent supply management practices
Unilife Accelerates Investment to Meet Increasing Demand from New and Existing Customers
Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call
Synageva BioPharma™ Reports Second Quarter 2014 Financial Results
Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission
Transluminal Technologies receives CE Mark approval for velox CD(TM) vascular closure device
Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake
Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant
Ebola Virus Gene Replikin Count Increased Sixteen-fold in 2013 in Advance of Current Outbreaks
InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada
Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer
GRAMMY® Award-Winning Singer Jennifer Hudson Lends Her Voice To Stand Up To Cancer And Genentech In "Two Worlds. One Dream." Campaign In The Fight Against Cancer
Wyle Wins NASA's Fully Integrated Lifecycle Mission Support Services Contract
UMD Researchers Bridge Gap between Microelectronics, Biological Systems
DigiPath No New Corporate Developments English
Lightlake Therapeutics Inc. Receives Funding Commitment From A Prominent International Research And Development Foundation
Nano-Bio Manufacturing Consortium Awards Funding to Binghamton University for Development of Electronics and Biometric Sensor Platforms
Access Pharmaceuticals Featured On
Thomas Dubinski joins Dyadic as Chief Financial Officer
invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors
CHMP Recommends Approval of Lilly's Humalog® 200 units/ml KwikPen®
Orexigen Receives CHMP Day 180 List of Outstanding Issues English
RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars
AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001
Ready-to-Use EZ-Fit™ Filtration Unit from EMD Millipore Leverages Industry Leading Technology for More Efficient Bioburden Testing of Liquids
Ready-to-Use EZ-Fit™ Filtration Unit from EMD Millipore Leverages Industry Leading Technology for More Efficient Bioburden Testing of Municipal Water, Environmental Samples and Beverages
PDL BioPharma to Participate in Jefferies 2014 Boston Healthcare Summit
Scientific Innovation Resolves Shaving Irritation
Epic Sciences Appoints Greg Lucier as Chairman of the Board of Directors
Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine
Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37
Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences
Sequenom Enters Into License Agreement With Mayo Medical Laboratories
Pfenex Announces Closing of Initial Public Offering

< Prev Next >
PR Newswire - United Business Media